Intra-ventricular thrombus resolution after anticoagulation therapy with rivaroxaban in patient with poor anticoagulation quality

被引：4

作者：

Asuncion Esteve-Pastor, Maria ^{[1
]}

Orenes-Pinero, Esteban ^{[1
]}

Roldan, Vanessa ^{[2
]}

Lacunza-Ruiz, Javier ^{[1
]}

Valdes, Mariano ^{[1
]}

Marin, Francisco ^{[1
]}

机构：

[1] Univ Murcia, Hosp Univ Virgen Arrixaca, Dept Cardiol, IMIB Arrixaca,CIBER CV, Murcia, Spain

[2] Univ Murcia, Hosp Univ Morales Meseguer, Dept Hematol & Clin Oncol, IMIB Arrixaca, Murcia, Spain

来源：

CARDIOLOGY JOURNAL | 2018年 / 25卷 / 01期

关键词：

VITAMIN-K ANTAGONIST; ATRIAL-FIBRILLATION; MYOCARDIAL-INFARCTION; ORAL ANTICOAGULANTS; PREVENTION; GUIDELINES; WARFARIN;

D O I：

10.5603/CJ.2018.0014

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：151 / 154

页数：4

共 16 条

[1] Factors Affecting Quality of Anticoagulation Control Among Patients With Atrial Fibrillation on Warfarin The SAMe-TT2R2 Score [J].

Apostolakis, Stavros ;

Sullivan, Renee M. ;

Olshansky, Brian ;

Lip, Gregory Y. H. .

CHEST, 2013, 144 (05) :1555-1563

[2] The SAMe-TT2R2 score and decision-making between a vitamin K antagonist or a non-vitamin K antagonist oral anticoagulant in patients with atrial fibrillation [J].

Asuncion Esteve-Pastor, Mario ;

Roldan, Vanessa ;

Valdes, Mariano ;

Lip, Gregory Y. H. ;

Marin, Francisco .

EXPERT REVIEW OF CARDIOVASCULAR THERAPY, 2016, 14 (02) :177-187

[3]

Gianstefani S, 2014, AM J CARDIOL, V113, P1111, DOI [10.1016/j.amjcard.2013.12.015, 10.1016/j.amjcard.2013.12,015]

[4] 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS [J].

Kirchhof, Paulus ;

Benussi, Stefano ;

Kotecha, Dipak ;

Ahlsson, Anders ;

Atar, Dan ;

Casadei, Barbara ;

Castella, Manuel ;

Diener, Hans-Christoph ;

Heidbuchel, Hein ;

Hendriks, Jeroen ;

Hindricks, Gerhard ;

Manolis, Antonis S. ;

Oldgren, Jonas ;

Popescu, Bogdan Alexandru ;

Schotten, Ulrich ;

Van Putte, Bart ;

Vardas, Panagiotis .

EUROPEAN HEART JOURNAL, 2016, 37 (38) :2893-+

[5] Direct Oral Anticoagulants New Drugs and New Concepts [J].

Levy, Jerrold H. ;

Spyropoulos, Alex C. ;

Samama, Charles M. ;

Douketis, James .

JACC-CARDIOVASCULAR INTERVENTIONS, 2014, 7 (12) :1333-1351

[6] Stroke prevention in atrial fibrillation: Past, present and future Comparing the guidelines and practical decision-making [J].

Lip, Gregory Y. H. ;

Freedman, Ben ;

De Caterina, Raffaele ;

Potpara, Tatjana S. .

THROMBOSIS AND HAEMOSTASIS, 2017, 117 (07) :1230-1239

[7] Left atrial thrombus resolution in atrial fibrillation or flutter: Results of a prospective study with rivaroxaban (X-TRA) and a retrospective observational registry providing baseline data (CLOT-AF) [J].

Lip, Gregory Y. H. ;

Hammerstingl, Christoph ;

Marin, Francisco ;

Cappato, Riccardo ;

Meng, Isabelle Ling ;

Kirsch, Bodo ;

van Eickels, Martin ;

Cohen, Ariel .

AMERICAN HEART JOURNAL, 2016, 178 :126-134

[8]

Makrides Constantinos Andreas, 2016, BMJ Case Rep, V2016, DOI 10.1136/bcr-2016-217843

[9] Rivaroxaban in Patients with a Recent Acute Coronary Syndrome [J].

Mega, Jessica L. ;

Braunwald, Eugene ;

Wiviott, Stephen D. ;

Bassand, Jean-Pierre ;

Bhatt, Deepak L. ;

Bode, Christoph ;

Burton, Paul ;

Cohen, Marc ;

Cook-Bruns, Nancy ;

Fox, Keith A. A. ;

Goto, Shinya ;

Murphy, Sabina A. ;

Plotnikov, Alexei N. ;

Schneider, David ;

Sun, Xiang ;

Verheugt, Freek W. A. ;

Gibson, C. Michael .

NEW ENGLAND JOURNAL OF MEDICINE, 2012, 366 (01) :9-19

[10] Efficacy of non-vitamin-K antagonist oral anticoagulants for intracardiac thrombi resolution in nonvalvular atrial fibrillation [J].

Orenes-Pinero, Esteban ;

Esteve-Pastor, Maria A. ;

Valdes, Mariano ;

Lip, Gregory Y. H. ;

Marin, Francisco .

DRUG DISCOVERY TODAY, 2017, 22 (10) :1565-1571

← 1 2 →